Gevo is having an incredibly strong day in the market today. When the opening bell rang, the stock found itself well in the green. While it has …
GEVO
Gevo, Inc. (NASDAQ:GEVO) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Monday. The firm presently has a $4.25 target price on the stock. Zacks Investment …
Gevo
5,943,064 shares of the stock traded hands. Gevo Inc is a renewable chemicals and next generation biofuels company. Zacks Investment Research cut shares of Gevo, Inc. Gevo said that isobutanol can also be …
Gevo
Gevo Inc. (GEVO) had a gap down of (0.58) pts or -14.32 pct below its …
previous close
Forward Pharma (NYSE: FWP) 63.4% HIGHER; Biogen Inc. (NASDAQ: BIIB) today announced that it has agreed to enter into a settlement and license agreement with Forward Pharma (NYSE: FWP), subject to the approval …
Forward Pharma
D5 RIN credits have historically had greater value in the marketplace than D6 RINs, potentially making Gevo’s isobutanol more valuable in the …
advanced biofuel
On January 5, Gevo, Inc. (NASDAQ: GEVO) completed its previously …
Gevo
Shares of Gevo (NASDAQ:GEVO) traded up 3.8741% during mid-day trading on Tuesday, hitting $4.2069. The stock had a trading volume of 1,238,375 shares. The company’s market capitalization is $27.67 million. Gevo
Investment